Instil Bio, Inc. OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax
Instil Bio, Inc. (TIL) reported OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax of -$42.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax · last filed 2026-08-13
- Instil Bio, Inc. oci, debt securities, available-for-sale, gain (loss), after adjustment and tax for the quarter ending 2026-06-30 was -$42.00K.
- Instil Bio, Inc. oci, debt securities, available-for-sale, gain (loss), after adjustment and tax for the quarter ending 2026-03-31 was -$80.00K.
- Instil Bio, Inc. oci, debt securities, available-for-sale, gain (loss), after adjustment and tax for the quarter ending 2025-12-31 was $20.00K.
- Instil Bio, Inc. oci, debt securities, available-for-sale, gain (loss), after adjustment and tax for the quarter ending 2025-09-30 was $71.00K, a 82.16% decline year-over-year.
- Instil Bio, Inc. oci, debt securities, available-for-sale, gain (loss), after adjustment and tax for fiscal 2025 was -$13.00K.
- Instil Bio, Inc. oci, debt securities, available-for-sale, gain (loss), after adjustment and tax for fiscal 2024 was -$48.00K, a 108.30% decline from fiscal 2023.
- Instil Bio, Inc. oci, debt securities, available-for-sale, gain (loss), after adjustment and tax for fiscal 2023 was $578.00K.
- Instil Bio, Inc. oci, debt securities, available-for-sale, gain (loss), after adjustment and tax for fiscal 2022 was -$415.00K.
| Period end | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax 3 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax 6 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax 9 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$42.00K 10-Q · filed 2026-08-13 | -$122.00K 10-Q · filed 2026-08-13 | -$102.00K derived: sum of 3 quarters · filed 2026-08-13 | -$31.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$80.00K 10-Q · filed 2026-05-15 | -$60.00K derived: sum of 2 quarters · filed 2026-05-15 | $11.00K derived: sum of 3 quarters · filed 2026-05-15 | -$29.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $91.00K derived: sum of 2 quarters · filed 2026-03-27 | $51.00K derived: sum of 3 quarters · filed 2026-08-13 | -$13.00K 10-K · filed 2026-03-27 |
| 2025-09-30 | $71.00K 10-Q · filed 2025-11-13 | $31.00K derived: sum of 2 quarters · filed 2026-08-13 | -$33.00K 10-Q · filed 2025-11-13 | -$161.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$40.00K 10-Q · filed 2026-08-13 | -$104.00K 10-Q · filed 2026-08-13 | -$232.00K derived: sum of 3 quarters · filed 2026-08-13 | $166.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$64.00K 10-Q · filed 2026-05-15 | -$192.00K derived: sum of 2 quarters · filed 2026-05-15 | $206.00K derived: sum of 3 quarters · filed 2026-05-15 | $147.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$128.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $270.00K derived: sum of 2 quarters · filed 2026-03-27 | $211.00K derived: sum of 3 quarters · filed 2026-03-27 | -$48.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | $398.00K 10-Q · filed 2025-11-13 | $339.00K derived: sum of 2 quarters · filed 2025-11-13 | $80.00K 10-Q · filed 2025-11-13 | $480.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$59.00K 10-Q · filed 2025-08-13 | -$318.00K 10-Q · filed 2025-08-13 | $82.00K derived: sum of 3 quarters · filed 2025-08-13 | $121.00K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | -$259.00K 10-Q · filed 2025-05-13 | $141.00K derived: sum of 2 quarters · filed 2025-05-13 | $180.00K derived: sum of 3 quarters · filed 2025-05-13 | $2.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $439.00K derived: sum of 2 quarters · filed 2025-03-04 | $261.00K derived: sum of 3 quarters · filed 2025-03-04 | $578.00K 10-K · filed 2025-03-04 |
| 2023-09-30 | $39.00K 10-Q · filed 2024-11-13 | -$139.00K derived: sum of 2 quarters · filed 2024-11-13 | $178.00K 10-Q · filed 2024-11-13 | $591.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$178.00K 10-Q · filed 2024-08-13 | $139.00K 10-Q · filed 2024-08-13 | $552.00K derived: sum of 3 quarters · filed 2024-08-13 | $383.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $317.00K 10-Q · filed 2024-05-10 | $730.00K derived: sum of 2 quarters · filed 2024-05-10 | $561.00K derived: sum of 3 quarters · filed 2024-05-10 | $225.00K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $413.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $244.00K derived: sum of 2 quarters · filed 2024-03-21 | -$92.00K derived: sum of 3 quarters · filed 2024-03-21 | -$415.00K 10-K · filed 2024-03-21 |
| 2022-09-30 | -$169.00K 10-Q · filed 2023-11-13 | -$505.00K derived: sum of 2 quarters · filed 2023-11-13 | -$828.00K 10-Q · filed 2023-11-13 | -$860.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$336.00K 10-Q · filed 2023-08-14 | -$659.00K 10-Q · filed 2023-08-14 | -$691.00K derived: sum of 3 quarters · filed 2023-08-14 | -$709.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$323.00K 10-Q · filed 2023-05-11 | -$355.00K derived: sum of 2 quarters · filed 2023-05-11 | -$373.00K derived: sum of 3 quarters · filed 2023-05-11 | -$373.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$50.00K derived: sum of 2 quarters · filed 2023-03-31 | -$50.00K derived: sum of 3 quarters · filed 2023-03-31 | -$50.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | -$18.00K 10-Q · filed 2022-11-14 | -$18.00K derived: sum of 2 quarters · filed 2022-11-14 | -$18.00K 10-Q · filed 2022-11-14 | -$18.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | $0.00 derived: sum of 3 quarters · filed 2022-08-12 | $0.00 derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-16 | $0.00 derived: sum of 2 quarters · filed 2022-05-16 | $0.00 derived: sum of 3 quarters · filed 2022-05-16 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | $0.00 derived: sum of 2 quarters · filed 2022-03-07 | $0.00 10-K · filed 2022-03-07 | |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |